Immune Dysregulation in Hepatitis C Patients With or Without Arthritis
NCT ID: NCT01195987
Last Updated: 2010-09-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2010-06-30
2011-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hepatitis C with Arthritis
No interventions assigned to this group
Hepatitis C without Arthritis
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Either interferon or antiviral naive or those who failed interferon or antiviral therapy more than 6 mo. prior to enrollment.
* 10 normal healthy controls- Hep C neg and without osteoarthritis (OA).
Exclusion Criteria
* Those with concomitant alcoholic liver disease
* Patients with Rheumatoid Arthritis (RA) or other autoimmune disorders.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St. Luke's Hospital
UNKNOWN
The Center for Rheumatic Disease, Allergy, & Immunology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Center for Rheumatic Disease, Allergy, & Immunology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nabih I Abdou, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Center for Rheumatic Disease, Allergy & Immunology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center for Rheumatic Disease, Allergy & Immunology
Kansas City, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Nabih I Abdou, MD, PhD
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09-290
Identifier Type: -
Identifier Source: org_study_id